编辑文章 - 后台系统

编辑文章

编辑文章

文章标题：

关键字：

所属疾病：

所属类别：

标　　签：

文章主图*

点击“Select image”更换图片

Select image Change Remove

注意! 最佳图片尺寸800*800

内容详情：

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><a href="http://www.india-drugstore.com/p/story_detail.php?id=1961&art_cate_value=0&art_navid_value=2"><span style="color:#3498db;"><strong><span style="font-size:12.0000pt"><span style="font-family:微软雅黑"><font face="微软雅黑">AMG510索托拉西布</font></span></span></strong></span></a><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">这是全球范围内首款靶向</font><font face="微软雅黑">KRAS蛋白的抗肿瘤药物。索托拉西布（</font></span></span></span></span></span></span></span><a href="https://www.cancer123.com/drugs/206/"><span class="15" style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">Sotorasib</font></span></span></span></span></span></span></span></a><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">,AMG510）的获批上市距离安进公司提交新药上市申请（NDA），仅仅6个月。</font></span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">2021年10月24日，《Targeted  Oncology》公布了CodeBreaK 100试验的后续分析数据，主要评估了索托拉西布在KRAS G12C突变的非小细胞</font></span></span></span></span></span></span></span><a href="https://www.cancer123.com/types/lung-cancer/"><span class="15" style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">肺癌</font></span></span></span></span></span></span></span></a><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">（</font><font face="微软雅黑">NSCLC）和稳定的脑转移患者中的疗效。</font></span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">索托拉西布正是根据</font>KRAS的致癌机制研发的一款药物，它能跟失活状态下的KRAS G12C突变蛋白结合，把异常激活的KRAS G12C蛋白强行拉回失活状态。索托拉西布的获批是基于II期CodeBreaK 100临床试验（NCT03600883）。</span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"> </p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">该研究共纳入了</font>124例既往接受过免疫治疗和/或化疗后出现疾病进展且携带KRAS G12C突变的局部晚期或转移性NSCLC患者，所有患者口服索托拉西布960mg,QD,直至疾病进展或发生不可耐受的毒性。</span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><img alt="" src="../upload/64b4dfe46a5f7413998174.jpg" style="width: 900px; height: 669px;" /></span></span></span></span></span></span></span></span></span></p>

首页显示：

显示不显示

热门文章：

是否

阅读：